APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pet Disease Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Research

Pet Disease Drugs Industry Research Report 2026

22 December 2025143 pages

Choose your research edition.

Industry ResearchPet Disease Drugs Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Pet Disease Drugs Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Pet Disease Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pet Disease Drugs Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Pet Disease Drugs Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

The global Pet Disease Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Pet Disease Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Pet Disease Drugs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Pet Disease Drugs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Pet Disease Drugs include Zoetis, Merck & Co., Inc., Zuche Pharmaceuticals, Virbac, Vetoquinol S.A., VETINDIA Pharmaceuticals, SOUND Technologies, SeQuent Scientific and Richter Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Pet Disease Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Pet Disease Drugs Market by Company

Zoetis

Merck & Co., Inc.

Zuche Pharmaceuticals

Virbac

Vetoquinol S.A.

VETINDIA Pharmaceuticals

SOUND Technologies

SeQuent Scientific

Richter Pharma

Ourofino Animal Health

Norbrook Laboratories

Multi Radiance Medical

Morvel Laboratories

LABINDIA Healthcare

K-Laser USA

IRM Enterprises

Fidelis Animal Health

Elanco Animal Health

Dechra Pharmaceuticals

Chanelle Pharma

Ceva

Century Pharmaceuticals

Calier

Boehringer Ingelheim

Bimeda

Avazzia

Assisi Animal Health

Ashish Life Science

Pet Disease Drugs Segment by Type

Analgesics

Anti-inflammatory

Parasiticides

Anti-infectives

Others

Pet Disease Drugs Segment by Application

Behavioral Diseases

Pain

Dermatologic Diseases

Orthopedic Diseases

Infectious Diseases

Other

Pet Disease Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet Disease Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pet Disease Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet Disease Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Pet Disease Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Pet Disease Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Pet Disease Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Pet Disease Drugs Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Pet Disease Drugs Sales (k units) of Manufacturers (2021-2026) Table 7. Global Pet Disease Drugs Sales Market Share by Manufacturers (2021-2026) Table 8. Global Pet Disease Drugs Revenue of Manufacturers (2021-2026) Table 9. Global Pet Disease Drugs Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Pet Disease Drugs Average Price (US$/unit) of Manufacturers (2021-2026) Table 11. Global Pet Disease Drugs Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Pet Disease Drugs, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Pet Disease Drugs, Product Type & Application Table 14. Global Pet Disease Drugs Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Pet Disease Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Zoetis Company Information Table 19. Zoetis Business Overview Table 20. Zoetis Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 21. Zoetis Pet Disease Drugs Product Portfolio Table 22. Zoetis Recent Developments Table 23. Merck & Co., Inc. Company Information Table 24. Merck & Co., Inc. Business Overview Table 25. Merck & Co., Inc. Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 26. Merck & Co., Inc. Pet Disease Drugs Product Portfolio Table 27. Merck & Co., Inc. Recent Developments Table 28. Zuche Pharmaceuticals Company Information Table 29. Zuche Pharmaceuticals Business Overview Table 30. Zuche Pharmaceuticals Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 31. Zuche Pharmaceuticals Pet Disease Drugs Product Portfolio Table 32. Zuche Pharmaceuticals Recent Developments Table 33. Virbac Company Information Table 34. Virbac Business Overview Table 35. Virbac Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 36. Virbac Pet Disease Drugs Product Portfolio Table 37. Virbac Recent Developments Table 38. Vetoquinol S.A. Company Information Table 39. Vetoquinol S.A. Business Overview Table 40. Vetoquinol S.A. Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 41. Vetoquinol S.A. Pet Disease Drugs Product Portfolio Table 42. Vetoquinol S.A. Recent Developments Table 43. VETINDIA Pharmaceuticals Company Information Table 44. VETINDIA Pharmaceuticals Business Overview Table 45. VETINDIA Pharmaceuticals Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. VETINDIA Pharmaceuticals Pet Disease Drugs Product Portfolio Table 47. VETINDIA Pharmaceuticals Recent Developments Table 48. SOUND Technologies Company Information Table 49. SOUND Technologies Business Overview Table 50. SOUND Technologies Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 51. SOUND Technologies Pet Disease Drugs Product Portfolio Table 52. SOUND Technologies Recent Developments Table 53. SeQuent Scientific Company Information Table 54. SeQuent Scientific Business Overview Table 55. SeQuent Scientific Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 56. SeQuent Scientific Pet Disease Drugs Product Portfolio Table 57. SeQuent Scientific Recent Developments Table 58. Richter Pharma Company Information Table 59. Richter Pharma Business Overview Table 60. Richter Pharma Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Richter Pharma Pet Disease Drugs Product Portfolio Table 62. Richter Pharma Recent Developments Table 63. Ourofino Animal Health Company Information Table 64. Ourofino Animal Health Business Overview Table 65. Ourofino Animal Health Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Ourofino Animal Health Pet Disease Drugs Product Portfolio Table 67. Ourofino Animal Health Recent Developments Table 68. Norbrook Laboratories Company Information Table 69. Norbrook Laboratories Business Overview Table 70. Norbrook Laboratories Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Norbrook Laboratories Pet Disease Drugs Product Portfolio Table 72. Norbrook Laboratories Recent Developments Table 73. Multi Radiance Medical Company Information Table 74. Multi Radiance Medical Business Overview Table 75. Multi Radiance Medical Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Multi Radiance Medical Pet Disease Drugs Product Portfolio Table 77. Multi Radiance Medical Recent Developments Table 78. Morvel Laboratories Company Information Table 79. Morvel Laboratories Business Overview Table 80. Morvel Laboratories Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Morvel Laboratories Pet Disease Drugs Product Portfolio Table 82. Morvel Laboratories Recent Developments Table 83. LABINDIA Healthcare Company Information Table 84. LABINDIA Healthcare Business Overview Table 85. LABINDIA Healthcare Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. LABINDIA Healthcare Pet Disease Drugs Product Portfolio Table 87. LABINDIA Healthcare Recent Developments Table 88. K-Laser USA Company Information Table 89. K-Laser USA Business Overview Table 90. K-Laser USA Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. K-Laser USA Pet Disease Drugs Product Portfolio Table 92. K-Laser USA Recent Developments Table 93. IRM Enterprises Company Information Table 94. IRM Enterprises Business Overview Table 95. IRM Enterprises Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. IRM Enterprises Pet Disease Drugs Product Portfolio Table 97. IRM Enterprises Recent Developments Table 98. Fidelis Animal Health Company Information Table 99. Fidelis Animal Health Business Overview Table 100. Fidelis Animal Health Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Fidelis Animal Health Pet Disease Drugs Product Portfolio Table 102. Fidelis Animal Health Recent Developments Table 103. Elanco Animal Health Company Information Table 104. Elanco Animal Health Business Overview Table 105. Elanco Animal Health Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. Elanco Animal Health Pet Disease Drugs Product Portfolio Table 107. Elanco Animal Health Recent Developments Table 108. Dechra Pharmaceuticals Company Information Table 109. Dechra Pharmaceuticals Business Overview Table 110. Dechra Pharmaceuticals Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 111. Dechra Pharmaceuticals Pet Disease Drugs Product Portfolio Table 112. Dechra Pharmaceuticals Recent Developments Table 113. Chanelle Pharma Company Information Table 114. Chanelle Pharma Business Overview Table 115. Chanelle Pharma Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 116. Chanelle Pharma Pet Disease Drugs Product Portfolio Table 117. Chanelle Pharma Recent Developments Table 118. Ceva Company Information Table 119. Ceva Business Overview Table 120. Ceva Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 121. Ceva Pet Disease Drugs Product Portfolio Table 122. Ceva Recent Developments Table 123. Century Pharmaceuticals Company Information Table 124. Century Pharmaceuticals Business Overview Table 125. Century Pharmaceuticals Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 126. Century Pharmaceuticals Pet Disease Drugs Product Portfolio Table 127. Century Pharmaceuticals Recent Developments Table 128. Calier Company Information Table 129. Calier Business Overview Table 130. Calier Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 131. Calier Pet Disease Drugs Product Portfolio Table 132. Calier Recent Developments Table 133. Boehringer Ingelheim Company Information Table 134. Boehringer Ingelheim Business Overview Table 135. Boehringer Ingelheim Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 136. Boehringer Ingelheim Pet Disease Drugs Product Portfolio Table 137. Boehringer Ingelheim Recent Developments Table 138. Bimeda Company Information Table 139. Bimeda Business Overview Table 140. Bimeda Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 141. Bimeda Pet Disease Drugs Product Portfolio Table 142. Bimeda Recent Developments Table 143. Avazzia Company Information Table 144. Avazzia Business Overview Table 145. Avazzia Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 146. Avazzia Pet Disease Drugs Product Portfolio Table 147. Avazzia Recent Developments Table 148. Assisi Animal Health Company Information Table 149. Assisi Animal Health Business Overview Table 150. Assisi Animal Health Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 151. Assisi Animal Health Pet Disease Drugs Product Portfolio Table 152. Assisi Animal Health Recent Developments Table 153. Ashish Life Science Company Information Table 154. Ashish Life Science Business Overview Table 155. Ashish Life Science Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 156. Ashish Life Science Pet Disease Drugs Product Portfolio Table 157. Ashish Life Science Recent Developments Table 158. Global Pet Disease Drugs Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 159. Global Pet Disease Drugs Sales by Region (2021-2026) & (k units) Table 160. Global Pet Disease Drugs Sales Market Share by Region (2021-2026) Table 161. Global Pet Disease Drugs Sales by Region (2027-2032) & (k units) Table 162. Global Pet Disease Drugs Sales Market Share by Region (2027-2032) Table 163. Global Pet Disease Drugs Revenue by Region (2021-2026) & (US$ Million) Table 164. Global Pet Disease Drugs Revenue Market Share by Region (2021-2026) Table 165. Global Pet Disease Drugs Revenue by Region (2027-2032) & (US$ Million) Table 166. Global Pet Disease Drugs Revenue Market Share by Region (2027-2032) Table 167. North America Pet Disease Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 168. North America Pet Disease Drugs Sales by Country (2021-2026) & (k units) Table 169. North America Pet Disease Drugs Sales by Country (2027-2032) & (k units) Table 170. North America Pet Disease Drugs Revenue by Country (2021-2026) & (US$ Million) Table 171. North America Pet Disease Drugs Revenue by Country (2027-2032) & (US$ Million) Table 172. Europe Pet Disease Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 173. Europe Pet Disease Drugs Sales by Country (2021-2026) & (k units) Table 174. Europe Pet Disease Drugs Sales by Country (2027-2032) & (k units) Table 175. Europe Pet Disease Drugs Revenue by Country (2021-2026) & (US$ Million) Table 176. Europe Pet Disease Drugs Revenue by Country (2027-2032) & (US$ Million) Table 177. Asia Pacific Pet Disease Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 178. Asia Pacific Pet Disease Drugs Sales by Country (2021-2026) & (k units) Table 179. Asia Pacific Pet Disease Drugs Sales by Country (2027-2032) & (k units) Table 180. Asia Pacific Pet Disease Drugs Revenue by Country (2021-2026) & (US$ Million) Table 181. Asia Pacific Pet Disease Drugs Revenue by Country (2027-2032) & (US$ Million) Table 182. South America Pet Disease Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 183. South America Pet Disease Drugs Sales by Country (2021-2026) & (k units) Table 184. South America Pet Disease Drugs Sales by Country (2027-2032) & (k units) Table 185. South America Pet Disease Drugs Revenue by Country (2021-2026) & (US$ Million) Table 186. South America Pet Disease Drugs Revenue by Country (2027-2032) & (US$ Million) Table 187. Middle East and Africa Pet Disease Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 188. Middle East and Africa Pet Disease Drugs Sales by Country (2021-2026) & (k units) Table 189. Middle East and Africa Pet Disease Drugs Sales by Country (2027-2032) & (k units) Table 190. Middle East and Africa Pet Disease Drugs Revenue by Country (2021-2026) & (US$ Million) Table 191. Middle East and Africa Pet Disease Drugs Revenue by Country (2027-2032) & (US$ Million) Table 192. Global Pet Disease Drugs Sales by Type (2021-2026) & (k units) Table 193. Global Pet Disease Drugs Sales by Type (2027-2032) & (k units) Table 194. Global Pet Disease Drugs Sales Market Share by Type (2021-2026) Table 195. Global Pet Disease Drugs Sales Market Share by Type (2027-2032) Table 196. Global Pet Disease Drugs Revenue by Type (2021-2026) & (US$ Million) Table 197. Global Pet Disease Drugs Revenue by Type (2027-2032) & (US$ Million) Table 198. Global Pet Disease Drugs Revenue Market Share by Type (2021-2026) Table 199. Global Pet Disease Drugs Revenue Market Share by Type (2027-2032) Table 200. Global Pet Disease Drugs Price by Type (2021-2026) & (US$/unit) Table 201. Global Pet Disease Drugs Price by Type (2027-2032) & (US$/unit) Table 202. Global Pet Disease Drugs Sales by Application (2021-2026) & (k units) Table 203. Global Pet Disease Drugs Sales by Application (2027-2032) & (k units) Table 204. Global Pet Disease Drugs Sales Market Share by Application (2021-2026) Table 205. Global Pet Disease Drugs Sales Market Share by Application (2027-2032) Table 206. Global Pet Disease Drugs Revenue by Application (2021-2026) & (US$ Million) Table 207. Global Pet Disease Drugs Revenue by Application (2027-2032) & (US$ Million) Table 208. Global Pet Disease Drugs Revenue Market Share by Application (2021-2026) Table 209. Global Pet Disease Drugs Revenue Market Share by Application (2027-2032) Table 210. Global Pet Disease Drugs Price by Application (2021-2026) & (US$/unit) Table 211. Global Pet Disease Drugs Price by Application (2027-2032) & (US$/unit) Table 212. Key Raw Materials Table 213. Raw Materials Key Suppliers Table 214. Pet Disease Drugs Distributors List Table 215. Pet Disease Drugs Customers List Table 216. Pet Disease Drugs Industry Trends Table 217. Pet Disease Drugs Industry Drivers Table 218. Pet Disease Drugs Industry Restraints Table 219. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Pet Disease Drugs Product Image Figure 5. Global Pet Disease Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Pet Disease Drugs Market Size (2021-2032) & (US$ Million) Figure 7. Global Pet Disease Drugs Sales (2021-2032) & (k units) Figure 8. Global Pet Disease Drugs Average Price (US$/unit) & (2021-2032) Figure 9. Analgesics Product Image Figure 10. Anti-inflammatory Product Image Figure 11. Parasiticides Product Image Figure 12. Anti-infectives Product Image Figure 13. Others Product Image Figure 14. Behavioral Diseases Product Image Figure 15. Pain Product Image Figure 16. Dermatologic Diseases Product Image Figure 17. Orthopedic Diseases Product Image Figure 18. Infectious Diseases Product Image Figure 19. Other Product Image Figure 20. Global Pet Disease Drugs Revenue Share by Manufacturers in 2025 Figure 21. Global Manufacturers of Pet Disease Drugs, Manufacturing Sites & Headquarters Figure 22. Global Top 5 and 10 Pet Disease Drugs Players Market Share by Revenue in 2025 Figure 23. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 24. Global Pet Disease Drugs Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 25. Global Pet Disease Drugs Sales by Region in 2025 Figure 26. Global Pet Disease Drugs Revenue by Region in 2025 Figure 27. North America Pet Disease Drugs Market Size by Country in 2025 Figure 28. North America Pet Disease Drugs Sales Market Share by Country (2021-2032) Figure 29. North America Pet Disease Drugs Revenue Market Share by Country (2021-2032) Figure 30. United States Pet Disease Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. Canada Pet Disease Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Mexico Pet Disease Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Europe Pet Disease Drugs Market Size by Country in 2025 Figure 34. Europe Pet Disease Drugs Sales Market Share by Country (2021-2032) Figure 35. Europe Pet Disease Drugs Revenue Market Share by Country (2021-2032) Figure 36. Germany Pet Disease Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. France Pet Disease Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. U.K. Pet Disease Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Italy Pet Disease Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Russia Pet Disease Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Spain Pet Disease Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Netherlands Pet Disease Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Switzerland Pet Disease Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Sweden Pet Disease Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Poland Pet Disease Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Asia Pacific Pet Disease Drugs Market Size by Country in 2025 Figure 47. Asia Pacific Pet Disease Drugs Sales Market Share by Country (2021-2032) Figure 48. Asia Pacific Pet Disease Drugs Revenue Market Share by Country (2021-2032) Figure 49. China Pet Disease Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Japan Pet Disease Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South Korea Pet Disease Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. India Pet Disease Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Australia Pet Disease Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Taiwan Pet Disease Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Southeast Asia Pet Disease Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Southeast Asia Pet Disease Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. South America Pet Disease Drugs Market Size by Country in 2025 Figure 58. South America Pet Disease Drugs Sales Market Share by Country (2021-2032) Figure 59. South America Pet Disease Drugs Revenue Market Share by Country (2021-2032) Figure 60. Brazil Pet Disease Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. Argentina Pet Disease Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Chile Pet Disease Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Middle East and Africa Pet Disease Drugs Market Size by Country in 2025 Figure 64. Middle East and Africa Pet Disease Drugs Sales Market Share by Country (2021-2032) Figure 65. Middle East and Africa Pet Disease Drugs Revenue Market Share by Country (2021-2032) Figure 66. Egypt Pet Disease Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. South Africa Pet Disease Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 68. Israel Pet Disease Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 69. Türkiye Pet Disease Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 70. GCC Countries Pet Disease Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 71. Global Pet Disease Drugs Sales Market Share by Type (2021-2032) Figure 72. Global Pet Disease Drugs Revenue Market Share by Type (2021-2032) Figure 73. Global Pet Disease Drugs Price (US$/unit) by Type (2021-2032) Figure 74. Global Pet Disease Drugs Sales Market Share by Application (2021-2032) Figure 75. Global Pet Disease Drugs Revenue Market Share by Application (2021-2032) Figure 76. Global Pet Disease Drugs Price (US$/unit) by Application (2021-2032) Figure 77. Pet Disease Drugs Value Chain Figure 78. Pet Disease Drugs Production Mode & Process Figure 79. Direct Comparison with Distribution Share Figure 80. Distributors Profiles Figure 81. Pet Disease Drugs Industry Opportunities and Challenges

Scope & coverage.

Types
  • Analgesics
  • Anti-inflammatory
  • Parasiticides
  • Anti-infectives
  • Others
Applications
  • Behavioral Diseases
  • Pain
  • Dermatologic Diseases
  • Orthopedic Diseases
  • Infectious Diseases
  • Other
Companies covered
  • Zoetis
  • Merck & Co., Inc.
  • Zuche Pharmaceuticals
  • Virbac
  • Vetoquinol S.A.
  • VETINDIA Pharmaceuticals
  • SOUND Technologies
  • SeQuent Scientific
  • Richter Pharma
  • Ourofino Animal Health
  • Norbrook Laboratories
  • Multi Radiance Medical
  • Morvel Laboratories
  • LABINDIA Healthcare
  • K-Laser USA
  • IRM Enterprises
  • Fidelis Animal Health
  • Elanco Animal Health
  • Dechra Pharmaceuticals
  • Chanelle Pharma
  • Ceva
  • Century Pharmaceuticals
  • Calier
  • Boehringer Ingelheim
  • Bimeda
  • Avazzia
  • Assisi Animal Health
  • Ashish Life Science

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Pet Disease Drugs Market Size (2021-2032)
  4. 2.2.2 Global Pet Disease Drugs Sales (2021-2032)
  5. 2.2.3 Global Pet Disease Drugs Market Average Price (2021-2032)
  6. 2.3 Pet Disease Drugs by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Analgesics
  9. 2.3.3 Anti-inflammatory
  10. 2.3.4 Parasiticides
  11. 2.3.5 Anti-infectives
  12. 2.3.6 Others
  13. 2.4 Pet Disease Drugs by Application
  14. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  15. 2.4.2 Behavioral Diseases
  16. 2.4.3 Pain
  17. 2.4.4 Dermatologic Diseases
  18. 2.4.5 Orthopedic Diseases
  19. 2.4.6 Infectious Diseases
  20. 2.4.7 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Pet Disease Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Pet Disease Drugs Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Pet Disease Drugs Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Pet Disease Drugs Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Pet Disease Drugs Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Pet Disease Drugs, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Pet Disease Drugs, Product Type & Application
  8. 3.8 Global Manufacturers of Pet Disease Drugs, Established Date
  9. 3.9 Global Pet Disease Drugs Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Zoetis
  2. 4.1.1 Zoetis Company Information
  3. 4.1.2 Zoetis Business Overview
  4. 4.1.3 Zoetis Pet Disease Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Zoetis Pet Disease Drugs Product Portfolio
  6. 4.1.5 Zoetis Recent Developments
  7. 4.2 Merck & Co., Inc.
  8. 4.2.1 Merck & Co., Inc. Company Information
  9. 4.2.2 Merck & Co., Inc. Business Overview
  10. 4.2.3 Merck & Co., Inc. Pet Disease Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Merck & Co., Inc. Pet Disease Drugs Product Portfolio
  12. 4.2.5 Merck & Co., Inc. Recent Developments
  13. 4.3 Zuche Pharmaceuticals
  14. 4.3.1 Zuche Pharmaceuticals Company Information
  15. 4.3.2 Zuche Pharmaceuticals Business Overview
  16. 4.3.3 Zuche Pharmaceuticals Pet Disease Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Zuche Pharmaceuticals Pet Disease Drugs Product Portfolio
  18. 4.3.5 Zuche Pharmaceuticals Recent Developments
  19. 4.4 Virbac
  20. 4.4.1 Virbac Company Information
  21. 4.4.2 Virbac Business Overview
  22. 4.4.3 Virbac Pet Disease Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Virbac Pet Disease Drugs Product Portfolio
  24. 4.4.5 Virbac Recent Developments
  25. 4.5 Vetoquinol S.A.
  26. 4.5.1 Vetoquinol S.A. Company Information
  27. 4.5.2 Vetoquinol S.A. Business Overview
  28. 4.5.3 Vetoquinol S.A. Pet Disease Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Vetoquinol S.A. Pet Disease Drugs Product Portfolio
  30. 4.5.5 Vetoquinol S.A. Recent Developments
  31. 4.6 VETINDIA Pharmaceuticals
  32. 4.6.1 VETINDIA Pharmaceuticals Company Information
  33. 4.6.2 VETINDIA Pharmaceuticals Business Overview
  34. 4.6.3 VETINDIA Pharmaceuticals Pet Disease Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 VETINDIA Pharmaceuticals Pet Disease Drugs Product Portfolio
  36. 4.6.5 VETINDIA Pharmaceuticals Recent Developments
  37. 4.7 SOUND Technologies
  38. 4.7.1 SOUND Technologies Company Information
  39. 4.7.2 SOUND Technologies Business Overview
  40. 4.7.3 SOUND Technologies Pet Disease Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 SOUND Technologies Pet Disease Drugs Product Portfolio
  42. 4.7.5 SOUND Technologies Recent Developments
  43. 4.8 SeQuent Scientific
  44. 4.8.1 SeQuent Scientific Company Information
  45. 4.8.2 SeQuent Scientific Business Overview
  46. 4.8.3 SeQuent Scientific Pet Disease Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 SeQuent Scientific Pet Disease Drugs Product Portfolio
  48. 4.8.5 SeQuent Scientific Recent Developments
  49. 4.9 Richter Pharma
  50. 4.9.1 Richter Pharma Company Information
  51. 4.9.2 Richter Pharma Business Overview
  52. 4.9.3 Richter Pharma Pet Disease Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Richter Pharma Pet Disease Drugs Product Portfolio
  54. 4.9.5 Richter Pharma Recent Developments
  55. 4.10 Ourofino Animal Health
  56. 4.10.1 Ourofino Animal Health Company Information
  57. 4.10.2 Ourofino Animal Health Business Overview
  58. 4.10.3 Ourofino Animal Health Pet Disease Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Ourofino Animal Health Pet Disease Drugs Product Portfolio
  60. 4.10.5 Ourofino Animal Health Recent Developments
  61. 4.11 Norbrook Laboratories
  62. 4.11.1 Norbrook Laboratories Company Information
  63. 4.11.2 Norbrook Laboratories Business Overview
  64. 4.11.3 Norbrook Laboratories Pet Disease Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Norbrook Laboratories Pet Disease Drugs Product Portfolio
  66. 4.11.5 Norbrook Laboratories Recent Developments
  67. 4.12 Multi Radiance Medical
  68. 4.12.1 Multi Radiance Medical Company Information
  69. 4.12.2 Multi Radiance Medical Business Overview
  70. 4.12.3 Multi Radiance Medical Pet Disease Drugs Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Multi Radiance Medical Pet Disease Drugs Product Portfolio
  72. 4.12.5 Multi Radiance Medical Recent Developments
  73. 4.13 Morvel Laboratories
  74. 4.13.1 Morvel Laboratories Company Information
  75. 4.13.2 Morvel Laboratories Business Overview
  76. 4.13.3 Morvel Laboratories Pet Disease Drugs Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Morvel Laboratories Pet Disease Drugs Product Portfolio
  78. 4.13.5 Morvel Laboratories Recent Developments
  79. 4.14 LABINDIA Healthcare
  80. 4.14.1 LABINDIA Healthcare Company Information
  81. 4.14.2 LABINDIA Healthcare Business Overview
  82. 4.14.3 LABINDIA Healthcare Pet Disease Drugs Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 LABINDIA Healthcare Pet Disease Drugs Product Portfolio
  84. 4.14.5 LABINDIA Healthcare Recent Developments
  85. 4.15 K-Laser USA
  86. 4.15.1 K-Laser USA Company Information
  87. 4.15.2 K-Laser USA Business Overview
  88. 4.15.3 K-Laser USA Pet Disease Drugs Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 K-Laser USA Pet Disease Drugs Product Portfolio
  90. 4.15.5 K-Laser USA Recent Developments
  91. 4.16 IRM Enterprises
  92. 4.16.1 IRM Enterprises Company Information
  93. 4.16.2 IRM Enterprises Business Overview
  94. 4.16.3 IRM Enterprises Pet Disease Drugs Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 IRM Enterprises Pet Disease Drugs Product Portfolio
  96. 4.16.5 IRM Enterprises Recent Developments
  97. 4.17 Fidelis Animal Health
  98. 4.17.1 Fidelis Animal Health Company Information
  99. 4.17.2 Fidelis Animal Health Business Overview
  100. 4.17.3 Fidelis Animal Health Pet Disease Drugs Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Fidelis Animal Health Pet Disease Drugs Product Portfolio
  102. 4.17.5 Fidelis Animal Health Recent Developments
  103. 4.18 Elanco Animal Health
  104. 4.18.1 Elanco Animal Health Company Information
  105. 4.18.2 Elanco Animal Health Business Overview
  106. 4.18.3 Elanco Animal Health Pet Disease Drugs Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Elanco Animal Health Pet Disease Drugs Product Portfolio
  108. 4.18.5 Elanco Animal Health Recent Developments
  109. 4.19 Dechra Pharmaceuticals
  110. 4.19.1 Dechra Pharmaceuticals Company Information
  111. 4.19.2 Dechra Pharmaceuticals Business Overview
  112. 4.19.3 Dechra Pharmaceuticals Pet Disease Drugs Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Dechra Pharmaceuticals Pet Disease Drugs Product Portfolio
  114. 4.19.5 Dechra Pharmaceuticals Recent Developments
  115. 4.20 Chanelle Pharma
  116. 4.20.1 Chanelle Pharma Company Information
  117. 4.20.2 Chanelle Pharma Business Overview
  118. 4.20.3 Chanelle Pharma Pet Disease Drugs Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 Chanelle Pharma Pet Disease Drugs Product Portfolio
  120. 4.20.5 Chanelle Pharma Recent Developments
  121. 4.21 Ceva
  122. 4.21.1 Ceva Company Information
  123. 4.21.2 Ceva Business Overview
  124. 4.21.3 Ceva Pet Disease Drugs Sales, Revenue and Gross Margin (2021-2026)
  125. 4.21.4 Ceva Pet Disease Drugs Product Portfolio
  126. 4.21.5 Ceva Recent Developments
  127. 4.22 Century Pharmaceuticals
  128. 4.22.1 Century Pharmaceuticals Company Information
  129. 4.22.2 Century Pharmaceuticals Business Overview
  130. 4.22.3 Century Pharmaceuticals Pet Disease Drugs Sales, Revenue and Gross Margin (2021-2026)
  131. 4.22.4 Century Pharmaceuticals Pet Disease Drugs Product Portfolio
  132. 4.22.5 Century Pharmaceuticals Recent Developments
  133. 4.23 Calier
  134. 4.23.1 Calier Company Information
  135. 4.23.2 Calier Business Overview
  136. 4.23.3 Calier Pet Disease Drugs Sales, Revenue and Gross Margin (2021-2026)
  137. 4.23.4 Calier Pet Disease Drugs Product Portfolio
  138. 4.23.5 Calier Recent Developments
  139. 4.24 Boehringer Ingelheim
  140. 4.24.1 Boehringer Ingelheim Company Information
  141. 4.24.2 Boehringer Ingelheim Business Overview
  142. 4.24.3 Boehringer Ingelheim Pet Disease Drugs Sales, Revenue and Gross Margin (2021-2026)
  143. 4.24.4 Boehringer Ingelheim Pet Disease Drugs Product Portfolio
  144. 4.24.5 Boehringer Ingelheim Recent Developments
  145. 4.25 Bimeda
  146. 4.25.1 Bimeda Company Information
  147. 4.25.2 Bimeda Business Overview
  148. 4.25.3 Bimeda Pet Disease Drugs Sales, Revenue and Gross Margin (2021-2026)
  149. 4.25.4 Bimeda Pet Disease Drugs Product Portfolio
  150. 4.25.5 Bimeda Recent Developments
  151. 4.26 Avazzia
  152. 4.26.1 Avazzia Company Information
  153. 4.26.2 Avazzia Business Overview
  154. 4.26.3 Avazzia Pet Disease Drugs Sales, Revenue and Gross Margin (2021-2026)
  155. 4.26.4 Avazzia Pet Disease Drugs Product Portfolio
  156. 4.26.5 Avazzia Recent Developments
  157. 4.27 Assisi Animal Health
  158. 4.27.1 Assisi Animal Health Company Information
  159. 4.27.2 Assisi Animal Health Business Overview
  160. 4.27.3 Assisi Animal Health Pet Disease Drugs Sales, Revenue and Gross Margin (2021-2026)
  161. 4.27.4 Assisi Animal Health Pet Disease Drugs Product Portfolio
  162. 4.27.5 Assisi Animal Health Recent Developments
  163. 4.28 Ashish Life Science
  164. 4.28.1 Ashish Life Science Company Information
  165. 4.28.2 Ashish Life Science Business Overview
  166. 4.28.3 Ashish Life Science Pet Disease Drugs Sales, Revenue and Gross Margin (2021-2026)
  167. 4.28.4 Ashish Life Science Pet Disease Drugs Product Portfolio
  168. 4.28.5 Ashish Life Science Recent Developments
5 Global Pet Disease Drugs Market Scenario by Region
  1. 5.1 Global Pet Disease Drugs Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Pet Disease Drugs Sales by Region: 2021-2032
  3. 5.2.1 Global Pet Disease Drugs Sales by Region: 2021-2026
  4. 5.2.2 Global Pet Disease Drugs Sales by Region: 2027-2032
  5. 5.3 Global Pet Disease Drugs Revenue by Region: 2021-2032
  6. 5.3.1 Global Pet Disease Drugs Revenue by Region: 2021-2026
  7. 5.3.2 Global Pet Disease Drugs Revenue by Region: 2027-2032
  8. 5.4 North America Pet Disease Drugs Market Facts & Figures by Country
  9. 5.4.1 North America Pet Disease Drugs Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Pet Disease Drugs Sales by Country (2021-2032)
  11. 5.4.3 North America Pet Disease Drugs Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Pet Disease Drugs Market Facts & Figures by Country
  16. 5.5.1 Europe Pet Disease Drugs Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Pet Disease Drugs Sales by Country (2021-2032)
  18. 5.5.3 Europe Pet Disease Drugs Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Pet Disease Drugs Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Pet Disease Drugs Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Pet Disease Drugs Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Pet Disease Drugs Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Pet Disease Drugs Market Facts & Figures by Country
  41. 5.7.1 South America Pet Disease Drugs Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Pet Disease Drugs Sales by Country (2021-2032)
  43. 5.7.3 South America Pet Disease Drugs Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Pet Disease Drugs Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Pet Disease Drugs Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Pet Disease Drugs Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Pet Disease Drugs Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Pet Disease Drugs Sales by Type (2021-2032)
  2. 6.1.1 Global Pet Disease Drugs Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Pet Disease Drugs Sales Market Share by Type (2021-2032)
  4. 6.2 Global Pet Disease Drugs Revenue by Type (2021-2032)
  5. 6.2.1 Global Pet Disease Drugs Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Pet Disease Drugs Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Pet Disease Drugs Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Pet Disease Drugs Sales by Application (2021-2032)
  2. 7.1.1 Global Pet Disease Drugs Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Pet Disease Drugs Sales Market Share by Application (2021-2032)
  4. 7.2 Global Pet Disease Drugs Revenue by Application (2021-2032)
  5. 7.2.1 Global Pet Disease Drugs Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Pet Disease Drugs Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Pet Disease Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Pet Disease Drugs Value Chain Analysis
  2. 8.1.1 Pet Disease Drugs Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Pet Disease Drugs Production Mode & Process
  5. 8.2 Pet Disease Drugs Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Pet Disease Drugs Distributors
  8. 8.2.3 Pet Disease Drugs Customers
9 Global Pet Disease Drugs Analyzing Market Dynamics
  1. 9.1 Pet Disease Drugs Industry Trends
  2. 9.2 Pet Disease Drugs Industry Drivers
  3. 9.3 Pet Disease Drugs Industry Opportunities and Challenges
  4. 9.4 Pet Disease Drugs Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst